Summary
✓Reviewed by Laura Bennett Nick Kyrgios, the Australian tennis player and 2022 Wimbledon finalist, has accepted a one-month suspension after testing positive for cocaine at an ATP 250 event in Mallorca, Spain on June 22, 2026, and became eligible to...
Table of contents
- 1 What the Anti-Doping Ruling Found
- 2 Kyrgios Acknowledges “Significant Error”
- 3 Timeline of the Case
- 4 How the Out-of-Competition Classification Changed the Outcome
- 5 Where This Leaves Kyrgios on the ATP Tour
- 6 Context: Tennis and Anti-Doping Cases in 2026
- 7 What Happens Next
- 8 Key Facts at a Glance
- 9 Sources
Nick Kyrgios, the Australian tennis player and 2022 Wimbledon finalist, has accepted a one-month suspension after testing positive for cocaine at an ATP 250 event in Mallorca, Spain on June 22, 2026, and became eligible to return to professional tennis on September 4, 2026, following a provisional ban that began on August 4.
What the Anti-Doping Ruling Found
The International Tennis Integrity Agency (ITIA) confirmed that Kyrgios had tested positive for benzoylecgonine, a metabolite of cocaine, with the positive result verified by a World Anti-Doping Agency (WADA)-accredited laboratory on July 17, 2026. The 31-year-old was provisionally suspended from August 4, 2026, pending the outcome of the anti-doping case.
Anti-doping authorities determined that the cocaine use occurred out of competition, which is a critical distinction under the WADA Code. An out-of-competition positive for a specified recreational substance carries a lower mandatory sanction than an in-competition positive, and Kyrgios was able to further reduce the penalty by enrolling in an approved treatment programme. That combination brought the sanction down from the standard minimum of three months to one month, according to ABC News Australia.
Kyrgios Acknowledges “Significant Error”
Kyrgios issued a public statement in which he acknowledged a “significant error” in judgement. “For the next 28 days, I will be stepping away from social media and public life to focus on my recovery,” the player said in the statement, as reported by ESPN. The statement was released as the one-month suspension concluded, clearing him to participate in events from September 4 onward.
The 28-day period referenced in his statement aligns with the August 4 start date of the provisional suspension, meaning Kyrgios served the effective ban while that statement was in circulation — and he is now fully eligible to re-enter ATP Tour competition.
Timeline of the Case
| Date | Event |
|---|---|
| June 22, 2026 | Kyrgios tests positive for cocaine at ATP 250 event in Mallorca, Spain |
| July 17, 2026 | Positive result verified by WADA-accredited laboratory |
| August 4, 2026 | Kyrgios provisionally suspended by the ITIA |
| September 3–4, 2026 | One-month ban accepted; ruling published; Kyrgios cleared to return |
| September 4, 2026 | Eligible to participate in professional tennis again |
How the Out-of-Competition Classification Changed the Outcome
The distinction between an in-competition and out-of-competition positive test is central to how this case was resolved. Under the WADA Code, cocaine is classified as a specified substance when detected outside of competition, meaning the player is presumed not to have used it for performance-enhancing purposes. The BBC reported that the severity of the ban hinged entirely on the timing of the positive result — had the drug been detected during competition, Kyrgios could have faced a suspension of up to four years. Instead, the out-of-competition classification opened the door to the more lenient one-month sanction once Kyrgios completed treatment programme requirements.
The Mallorca ATP 250 event where the sample was collected took place on June 22 — during the European grass-court season, weeks before Wimbledon. Kyrgios was not competing at Wimbledon 2026, having missed the tournament.
Tennis anti-doping outcomes involving recreational substances have been scrutinised in recent years, and this case is likely to renew debate about how the sport’s governance bodies balance player welfare against the integrity of competition. For readers following the broader tennis landscape, our Wimbledon 2026 preview outlines how the men’s draw shaped up earlier this summer without Kyrgios in the mix.
Where This Leaves Kyrgios on the ATP Tour
Kyrgios turned 31 in April 2026 and has been one of tennis’s most polarising figures across the past decade — celebrated for his shotmaking ability and match-winning instincts, but persistently dogged by controversy both on and off the court. His return eligibility from September 4 means he could theoretically enter events on the Asian swing, though no entry confirmations were publicly available at the time of reporting.
The WTA Singapore Tennis Open, scheduled for September 21–27 at OCBC Arena and headlined by players including Alexandra Eala and Jessica Pegula, represents the kind of marquee Asian-swing event that typically falls in a period where Kyrgios has previously considered competing. However, the Singapore event is a WTA tournament and Kyrgios, who competes on the ATP Tour, would not be eligible to enter it regardless of his suspension status.
The US Open is currently under way in New York. Kyrgios was not in the main draw, meaning his return to competition would most likely come at an ATP Tour event in September or October 2026. His ranking has dropped significantly during his absence from the tour and will require rebuilding through consistent match play.
Context: Tennis and Anti-Doping Cases in 2026
Kyrgios’s case is one of several anti-doping matters that have drawn media attention in professional tennis over the past year. The sport has faced ongoing scrutiny over the consistency of its sanctions, particularly for recreational substances that carry no performance-enhancing benefit in a competitive context. Governing bodies including the ITIA have repeatedly defended the differentiated treatment of in-competition and out-of-competition samples as aligned with global anti-doping standards set by WADA.
For context on how major tennis stories have unfolded in 2026, the dramatic first-round US Open upset involving Mariano Navone defeating Novak Djokovic in five sets earlier this week underscores how unsettled the men’s game has been heading into the back half of the season — with Kyrgios’s return now adding another variable to a crowded field.
What Happens Next
As of September 4, 2026, Kyrgios is fully cleared to compete in ATP Tour events. Key questions now centre on which tournaments he will enter, whether his game has remained at a competitive level during the suspension period, and how the ATP Tour will respond to his return in terms of wild-card allocations and seedings given the ranking points he has lost. His agent had not confirmed a first post-ban tournament as of the time of reporting.
The ITIA statement confirming the outcome of the case was published on September 3–4, 2026. No further sanctions are pending in relation to this matter, according to the anti-doping authority’s ruling.
Key Facts at a Glance
- Player: Nick Kyrgios, Australia, ATP Tour
- Substance: Benzoylecgonine (cocaine metabolite)
- Test date: June 22, 2026 (ATP 250, Mallorca, Spain)
- Lab verification: July 17, 2026
- Provisional suspension began: August 4, 2026
- Ban length accepted: One month (reduced from standard three-month minimum)
- Reduction basis: Out-of-competition use; enrolment in approved treatment programme
- Return eligibility: September 4, 2026
- Status: Fully eligible to compete; no further sanctions pending
